Infertility Drugs and Devices Market, By Type (Infertility Drugs, Infertility Devices ), By Gender, By Region - Size, Share, Outlook, and Opportunity Analysis, 2022

Description

Infertility Drugs and Devices used for treating infertility in male and female. Factors such as endometriosis, ovarian disorders, uterine disorders, tubal disorders, and hormonal disorders are the major cause of female infertility, whereas male infertility is caused by azoospermia, varicocele, ejaculation disorders, and erectile dysfunction. Treatment procedure constitutes of drugs, Assisted Reproductive Technology (ART), surgery, artificial insemination, and in vitro fertilization. Increasing prevalence of erectile dysfunction, increasing research and development, new product approval, and adoption of expansion strategies from major players operating in the market is expected to propel the market growth during the forecast period.

Key features of the study:

This report provides in-depth analysis of the Global Infertility Drugs and Devices market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the Global Infertility Drugs and Devices market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Apricus Biosciences, Inc., Bayer AG, Cristalia Produtos Quimicos Farmaceuticos Ltda., Dong-A Pharmaceutical Co. Ltd., Eli Lilly and Company, Meda Pharmaceuticals, Inc., Pfizer, Inc., S.K. Chemicals Co. Ltd., Vivus, Inc., Mylan Pharmaceuticals Inc., Ferring Pharmaceuticals, Cipla Ltd, Aspargo Laboratories, Inc., Aurobindo Pharma Ltd., Lupin Limited, Novartis International AG, Dare Bioscience, Inc., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals, and Dr. Reddys Laboratories Ltd
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The Global Infertility Drugs and Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Infertility Drugs and Devices market

Detailed Segmentation:

Global Infertility Drugs and Devices Market, By Type:
- Infertility Drugs
  - Clomiphene citrate
  - Sex hormones
  - Gonadotropins
  - Bromocriptine
  - Cabergoline
  - Imipramine
  - Letrozole
  - Metformin
- Infertility Devices
  - Equipment
  - Accessories
Global Infertility Drugs and Devices Market, By Gender:
- Male
- Female
Global Infertility Drugs and Devices Market, By Region:
- North America
  - By Type:
  - Infertility Drugs
  - Clomiphene citrate
  - Sex hormones
  - Gonadotropins
  - Bromocriptine
  - Cabergoline
  - Imipramine
  - Letrozole
  - Metformin
  - Infertility Devices
  - Equipment
  - Accessories
  - By Gender
  - Male
  - Female
  - By Country
  - U.S.
  - Canada
- Latin America
  - By Type:
  - Infertility Drugs
  - Clomiphene citrate
  - Sex hormones
  - Gonadotropins
  - Bromocriptine
  - Cabergoline
  - Imipramine
  - Letrozole
  - Metformin
  - Infertility Devices
  - Equipment
  - Accessories
  - By Gender
  - Male
  - Female
  - By Country
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - By Type:
  - Infertility Drugs
  - Clomiphene citrate
  - Sex hormones
  - Gonadotropins
  - Bromocriptine
  - Cabergoline
  - Imipramine
  - Letrozole
  - Metformin
  - Infertility Devices
  - Equipment
  - Accessories
  - By Gender
  - Male
  - Female
  - By Country
  - U.K.
  - Germany
  - France
  - Spain
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - By Type:
  - Infertility Drugs
  - Clomiphene citrate
  - Sex hormones
  - Gonadotropins
  - Bromocriptine
  - Cabergoline
  - Imipramine
  - Letrozole
  - Metformin
  - Infertility Devices
  - Equipment
  - Accessories
  - By Gender
  - Male
  - Female
  - By Country
  - China
  - Japan
  - India
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - By Type:
  - Infertility Drugs
  - Clomiphene citrate
  - Sex hormones
  - Gonadotropins
  - Bromocriptine
  - Cabergoline
  - Imipramine
  - Letrozole
  - Metformin
  - Infertility Devices
  - Equipment
  - Accessories
  - By Gender
  - Male
  - Female
  - By Country
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - By Type:
  - Infertility Drugs
  - Clomiphene citrate
  - Sex hormones
  - Gonadotropins
  - Bromocriptine
  - Cabergoline
  - Imipramine
  - Letrozole
  - Metformin
  - Infertility Devices
  - Equipment
  - Accessories
  - By Gender
  - Male
  - Female
  - By Country
  - North Africa
  - Central Africa
  - South Africa
Company Profiles
- Apricus Biosciences, Inc. *
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Bayer AG
- Cristalia Produtos Quimicos Farmaceuticos Ltda.
- Dong-A Pharmaceutical Co. Ltd.
- Eli Lilly and Company
- Meda Pharmaceuticals, Inc.
- Pfizer, Inc.
- S.K. Chemicals Co. Ltd.
- Vivus, Inc.
- Mylan Pharmaceuticals Inc.
- Ferring Pharmaceuticals
- Cipla Ltd
- Aspargo Laboratories, Inc.
- Aurobindo Pharma Ltd.
- Lupin Limited
- Novartis International AG
- Dare Bioscience, Inc.
- Torrent Pharmaceuticals Ltd.
- Alembic Pharmaceuticals
- Dr. Reddys Laboratories Ltd
"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI4122

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Type
- Market Snippet, By Gender
- Market Snippet, By Country
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Key Highlights
Product launch
PEST Analysis
Technological Advancements
Regulatory Scenario
Mergers and Acquisitions
Impact of COVID19 on market

4. Global Infertility Drugs and Devices Market, By Type, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Infertility Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Clomiphene citrate
- Sex hormones
- Gonadotropins
- Bromocriptine
- Cabergoline
- Imipramine
- Letrozole
- Metformin
Infertility Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Equipment
- Accessories

5. Global Infertility Drugs and Devices Market, By Gender, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Infertility Drugs and Devices Market, By Region, 2017 - 2028, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
North America
- Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Gender, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
Latin America
- Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Gender, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Gender, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Germany
- U.K.
- France
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Gender, 2017 - 2028, (US$ Mn))
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Gender, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- GCC Countries
- Israel
- Rest of Middle East
Africa
- Market Size and Forecast, By Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Gender, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- North Africa
- Central Africa
- South Africa

7. Competitive Landscape

Company Profiles
- Apricus Biosciences, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bayer AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cristalia Produtos Quimicos Farmaceuticos Ltda.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Dong-A Pharmaceutical Co. Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Eli Lilly and Company
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Meda Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- S.K. Chemicals Co. Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Vivus, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Mylan Pharmaceuticals Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Ferring Pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cipla Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Aspargo Laboratories, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Aurobindo Pharma Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Lupin Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Novartis International AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Dare Bioscience, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Torrent Pharmaceuticals Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Alembic Pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Dr. Reddys Laboratories Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies

8. Section

References
Research Methodology
About us and Sales Contact

Infertility Drugs and Devices Market, By Type (Infertility Drugs, Infertility Devices ), By Gender, By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028